相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Daratumumab in high-risk relapsed/refractory multiple myeloma patients: adverse effect of chromosome 1q21 gain/amplification and GEP70 status on outcome
Meera Mohan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Multiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive disease
Mike J. Mason et al.
LEUKEMIA (2020)
STAT3: A Promising Therapeutic Target in Multiple Myeloma
Phyllis S. Y. Chong et al.
CANCERS (2019)
The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
Nathan Kelley et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
A Network Analysis of Multiple Myeloma Related Gene Signatures
Yu Liu et al.
CANCERS (2019)
High Throughput Drug Synergy Testing in a Clinical Trial of Panobinostat, Carfilzomib, Dexamethasone to Define Response Biomarkers for Relapsed/Refractory Multiple Myeloma
Pamela S. Becker et al.
BLOOD (2019)
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2019)
Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma
A. Lagana et al.
LEUKEMIA (2018)
Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment
Kyohei Nakamura et al.
CANCER CELL (2018)
Pathogenesis of bone disease in multiple myeloma: from bench to bedside
Evangelos Terpos et al.
BLOOD CANCER JOURNAL (2018)
The NF-κB Activating Pathways in Multiple Myeloma
Payel Roy et al.
BIOMEDICINES (2018)
Genomic complexity of multiple myeloma and its clinical implications
Salomon Manier et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
SCENIC: single-cell regulatory network inference and clustering
Sara Aibar et al.
NATURE METHODS (2017)
Interleukin-32α promotes the proliferation of multiple myeloma cells by inducing production of IL-6 in bone marrow stromal cells
Xuanru Lin et al.
ONCOTARGET (2017)
Complete hazard ranking to analyze right-censored data: An ALS survival study
Zhengnan Huang et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
Efficient and accurate causal inference with hidden confounders from genome-transcriptome variation data
Lingfei Wang et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
Multiple myeloma
Shaji K. Kumar et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss
Muhammad Zahoor et al.
BLOOD ADVANCES (2017)
Evolutionary biology of high-risk multiple myeloma
Charlotte Pawlyn et al.
NATURE REVIEWS CANCER (2017)
FOXM1 is a therapeutic target for high-risk multiple myeloma
C. Gu et al.
LEUKEMIA (2016)
Causal Mechanistic Regulatory Network for Glioblastoma Deciphered Using Systems Genetics Network Analysis
Christopher L. Plaisier et al.
CELL SYSTEMS (2016)
Pathogenesis beyond the cancer clone(s) in multiple myeloma
Giada Bianchi et al.
BLOOD (2015)
Contribution of the Type II Chaperonin, TRiC/CCT, to Oncogenesis
Soung-Hun Roh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Soluble NKG2D ligand promotes MDSC expansion and skews macrophage to the alternatively activated phenotype
Gang Xiao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
A multilevel pan-cancer map links gene mutations to cancer hallmarks
Theo A. Knijnenburg et al.
CHINESE JOURNAL OF CANCER (2015)
Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
Jens G. Lohr et al.
CANCER CELL (2014)
A methodology to compare Dimensionality Reduction algorithms in terms of loss of quality
Antonio Gracia et al.
INFORMATION SCIENCES (2014)
A system-level model for the microbial regulatory genome
Aaron N. Brooks et al.
MOLECULAR SYSTEMS BIOLOGY (2014)
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Jan Kroenke et al.
SCIENCE (2014)
Modulation of STAT3 Folding and Function by TRiC/CCT Chaperonin
Moses Kasembeli et al.
PLOS BIOLOGY (2014)
Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities
Cirino Botta et al.
FRONTIERS IN ONCOLOGY (2014)
Network-based stratification of tumor mutations
Matan Hofree et al.
NATURE METHODS (2013)
Clinical and prognostic role of annexinA2 in multiple myeloma
Anja Seckinger et al.
BLOOD (2012)
A miRNA-regulatory network explains how dysregulated miRNAs perturb oncogenic processes across diverse cancers
Christopher L. Plaisier et al.
GENOME RESEARCH (2012)
B and T Lymphocyte Attenuator Mediates Inhibition of Tumor-Reactive CD8+ T Cells in Patients After Allogeneic Stem Cell Transplantation
Willemijn Hobo et al.
JOURNAL OF IMMUNOLOGY (2012)
A gene expression signature for high-risk multiple myeloma
R. Kuiper et al.
LEUKEMIA (2012)
A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer Cells
Lars Anders et al.
CANCER CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The Reconstruction of Transcriptional Networks Reveals Critical Genes with Implications for Clinical Outcome of Multiple Myeloma
Luca Agnelli et al.
CLINICAL CANCER RESEARCH (2011)
Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma
Dirk Hose et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
MEDICAL PROGRESS Multiple Myeloma
Antonio Palumbo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients
Annemiek Broyl et al.
BLOOD (2010)
The MicroArray Quality Control (MAQC)-IIII study of common practices for the development and validation of microarray-based predictive models
Leming Shi et al.
NATURE BIOTECHNOLOGY (2010)
Inferring Regulatory Networks from Expression Data Using Tree-Based Methods
Van Anh Huynh-Thu et al.
PLOS ONE (2010)
A scaling normalization method for differential expression analysis of RNA-seq data
Mark D. Robinson et al.
GENOME BIOLOGY (2010)
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Siddhartha Jaiswal et al.
CELL (2009)
The Cooperative Induction of Hypoxia-Inducible Factor-1α and STAT3 during Hypoxia Induced an Impairment of Tumor Susceptibility to CTL-Mediated Cell Lysis
Muhammad Zaeem Noman et al.
JOURNAL OF IMMUNOLOGY (2009)
Using genetic markers to orient the edges in quantitative trait networks: The NEO software
Jason E. Aten et al.
BMC SYSTEMS BIOLOGY (2008)
NFAT binding and regulation of T cell activation by the cytoplasmic scaffolding Homer proteins
Guo N. Huang et al.
SCIENCE (2008)
GCIP/CCNDBP1, a helix-loop-helix protein, suppresses tumorigenesis
Wenbin Ma et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1
John D. Shaughnessy et al.
BLOOD (2007)
Large-scale mapping and validation of Escherichia coli transcriptional regulation from a compendium of expression profiles
Jeremiah J. Faith et al.
PLOS BIOLOGY (2007)
Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing γδ T cell cytotoxicity
Angela Maerten et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
The molecular classification of multiple myeloma
Fenghuang Zhan et al.
BLOOD (2006)
DRAM, a p53-induced modulator of autophagy, is critical for apoptosis
Diane Crighton et al.
CELL (2006)
Integrated biclustering of heterogeneous genome-wide datasets for the inference of global regulatory networks
David J. Reiss et al.
BMC BIOINFORMATICS (2006)
ARACNE: An algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context
AA Margolin et al.
BMC BIOINFORMATICS (2006)
The Inferelator: an algorithm for learning parsimonious regulatory networks from systems-biology data sets de novo
Richard Bonneau et al.
GENOME BIOLOGY (2006)
Nuclear factor-κB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis
AC Bharti et al.
BLOOD (2004)
Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion
M Abe et al.
BLOOD (2004)
Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma
ES Doubrovina et al.
JOURNAL OF IMMUNOLOGY (2003)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
The role of tumor necrosis factor α in the pathophysiology of human multiple myeloma:: therapeutic applications
T Hideshima et al.
ONCOGENE (2001)
GCIP, a novel human Grap2 and cyclin D interacting protein, regulates E2F-mediated transcriptional activity
CZ Xia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Role of CD47 as a marker of self on red blood cells
PA Oldenborg et al.
SCIENCE (2000)
分享论文
